How Does Airomir Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Airomir Works
- Active ingredient: Salbutamol sulfate – a selective beta2‑adrenoceptor agonist.
- Primary action: Relaxes bronchial smooth muscle by increasing intracellular cAMP, providing rapid relief from wheezing and breathlessness.
- Onset & duration: Bronchodilation begins within 5–15 minutes; effects last 4–6 hours.
- Metabolism: Mainly hepatic sulfation to an inactive metabolite; excreted via urine (≈64%) and faeces.
- Role in asthma: Used as a “reliever” inhaler – on‑demand for symptoms or before exercise.
Airomir contains salbutamol sulfate, a fast‑acting bronchodilator that opens airways by directly relaxing the smooth muscle surrounding bronchial tubes. This page explains the science behind its mechanism, from molecular structure to clinical effects.
Important Medical Advice
If your usual dose of Airomir becomes less effective or does not last as long, seek medical help immediately – this may indicate worsening asthma. Do not exceed 16 puffs in 24 hours unless directed by your doctor. In case of sudden severe breathing difficulty, call 999.
Chemical Composition & Molecular Structure
Airomir Autohaler delivers salbutamol sulfate, a synthetic sympathomimetic amine. Each metered dose contains 100 micrograms of salbutamol (equivalent to 120 micrograms salbutamol sulfate). The inactive ingredients are ethanol, oleic acid, and the propellant norflurane (HFA‑134a).
Structural Details
(RS)-2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol sulfate (2:1)
A chiral phenol with a tertiary butyl group that confers beta2 selectivity. The sulfate salt enhances stability and solubility. The molecule exists as a racemic mixture; the (R)-enantiomer is primarily responsible for bronchodilation.
Key Pharmaceutical Properties
| Property | Value |
|---|---|
| Molecular formula (free base) | C₁₃H₂₁NO₃ |
| Molecular weight (sulfate) | 576.7 g/mol (as salt) |
| logP (octanol/water) | 1.5 (moderately hydrophilic) |
| pKa | 9.3 (amine), 10.3 (phenol) |
| Protein binding | ~10% |
| Solubility | Freely soluble in water; slightly soluble in ethanol |
🗒️ Pharmaceutical insight: The hydrophilic nature of salbutamol allows it to dissolve rapidly in airway lining fluid, making it quickly available to beta2 receptors.
Mechanism of Action: Airomir's Bronchodilator Pathway
Salbutamol is a selective beta2‑adrenoceptor agonist. When inhaled, it binds to beta2 receptors densely located on airway smooth muscle cells. This triggers a G‑protein‑cascade:
- Receptor activation: Binding of salbutamol to the beta2 receptor activates the stimulatory G‑protein (Gs).
- Adenylate cyclase stimulation: Gs activates adenylate cyclase, which converts ATP to cyclic AMP (cAMP).
- Protein kinase A (PKA) activation: Elevated cAMP activates PKA, which phosphorylates multiple target proteins.
- Reduction in intracellular calcium: PKA inhibits myosin light‑chain kinase, promotes calcium uptake by sarcoplasmic reticulum, and opens large‑conductance potassium channels – all leading to smooth muscle relaxation.
Additionally, salbutamol may inhibit mast cell mediator release and enhance mucociliary clearance, though its primary action is direct bronchodilation.
| Feature | Salbutamol (Airomir) |
|---|---|
| Onset of action | 5–15 minutes |
| Peak effect | 60–90 minutes |
| Duration | 4–6 hours |
| Receptor selectivity | Beta2 > Beta1 (approx 20:1) |
🗒️ Physiological insight: The rapid onset makes salbutamol the preferred “reliever” for acute asthma symptoms, while its short duration suits on‑demand use.
Absorption & Distribution (Pharmacokinetics)
After inhalation from Airomir Autohaler, approximately 10–20% of the emitted dose reaches the lower airways; the remainder is deposited in the oropharynx and swallowed.
Pulmonary absorption
The fraction reaching the lungs is absorbed rapidly into the systemic circulation, reaching peak plasma concentration within 2–4 hours. The swallowed portion is absorbed from the gut but undergoes extensive first‑pass sulfation in the gut wall and liver, contributing to low oral bioavailability (~50%).
Distribution
Salbutamol has a large volume of distribution (~156 L), indicating extensive tissue uptake. It crosses the placenta and is excreted in breast milk in small amounts. Plasma protein binding is minimal (~10%).
Metabolic Effects & Elimination
Metabolism: In humans, salbutamol is predominantly metabolised by conjugation to an inactive sulfate ester (salbutamol 4′‑O‑sulfate) via the enzyme SULT1A3 in the gut wall and liver. Only a small fraction undergoes oxidative deamination or glucuronidation.
Elimination: Approximately 64% of a dose is excreted in urine (30% as unchanged drug, 34% as metabolite) and 36% in faeces. The elimination half‑life is 3–6 hours. Total clearance is around 480 mL/min.
⚠️ Metabolic caution: High doses can cause hypokalaemia due to beta2‑mediated intracellular shift of potassium. This effect is transient but may be significant in severe asthma or concomitant use of certain diuretics.
Clinical Efficacy in Asthma Management
Airomir is indicated for symptomatic relief of asthma and for the prevention of exercise‑induced bronchoconstriction. In clinical practice:
- Symptom relief: Most patients experience significant improvement in FEV₁ within 15 minutes, with maximum effect at 1–2 hours.
- Exercise‑induced bronchoconstriction: Two puffs taken 15 minutes before exercise can prevent airway narrowing for up to 4 hours.
- Safety profile: At recommended doses, cardiovascular effects (e.g., tachycardia) are mild. However, overuse can lead to tremor, palpitations, and metabolic disturbances.
Airomir should be used as part of a comprehensive asthma management plan, which may include inhaled corticosteroids for long‑term control. Regular review with a healthcare professional is essential.
Airomir FAQs
How quickly does Airomir start working?
Airomir begins to work within 5–15 minutes after inhalation, making it ideal for rapid relief of acute asthma symptoms.
Can I use Airomir every day?
Airomir is a reliever inhaler intended for on‑demand use. If you need it more than twice a week, your asthma may be poorly controlled – consult your doctor.
What are the common side effects of Airomir?
Fine tremor of the hands, headache, palpitations, and mild tachycardia are the most frequent. These are usually mild and temporary.
Is Airomir safe for children?
Yes, Airomir can be used in children, but they should be supervised by an adult to ensure correct inhaler technique. The dose is the same as for adults (1–2 puffs).
Can I use Airomir if I am pregnant?
Use only if clearly needed and prescribed by your doctor. Uncontrolled asthma poses greater risks; discuss the balance with your healthcare provider.
Need Airomir with Expert Guidance?
If you have asthma and require a reliable reliever, our UK‑registered doctors can provide a prescription after an online consultation.
Secure Prescription & Next-Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Asthma ConsultationRelated Airomir Guides
Clinical References & Sources
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 9 March 2026
Next Review: 9 September 2026
Published on: 9 March 2026
Last Updated: 9 March 2026